NERVGEN PHARMA CORP. Net Income
Quick Answer NERVGEN PHARMA CORP. reported net income of -C$44.12 million for fiscal year 2025 (IFRS, Form 20-F). Reported under IFRS (SEC Form 20-F). Figures are shown in USD where the company provided them, otherwise in its reporting currency — each value exactly as filed with the SEC, not converted. NERVGEN PHARMA CORP. Net Income … Read more